Bowel Cancer in a Scottish Family: Use Scottish Numbers

If you are asking how common bowel cancer is in Scotland, you are asking an incidence question — how many people are diagnosed — and Scotland publishes its own answer to it. Public Health Scotland collects cancer incidence for the Scottish population, and bowel cancer is consistently one of the most commonly diagnosed cancers there. That is the figure you actually want, and it is not the one most search results hand you.

The problem is that a great deal of what surfaces online for "bowel cancer statistics" is English survival data, which answers a completely different question. Survival describes what happens to people after they are diagnosed. Incidence describes how likely a diagnosis is in the first place. They are separate measures, drawn from separate publications, and for a Scottish reader they are often drawn from the wrong country as well.

This page keeps the two apart. It explains why "how common is it" is an incidence question, why Scotland's own figures are the right ones to reason from, and what the numbers do and do not tell you if bowel cancer has appeared in your family.

The short answer: reason from Scottish incidence figures

When you want to know how common a cancer is where you live, the measure you need is incidence: the number of new cases diagnosed in a population over a period, usually a year. Public Health Scotland is the body that compiles this for Scotland, drawing on the Scottish cancer registry, and it reports bowel cancer — often called colorectal cancer — as one of the country's most frequently diagnosed cancers, alongside lung, breast and prostate.

That is the honest headline, and it is deliberately not dressed up with a precise-sounding rate lifted from somewhere else. The exact counts move year to year and are revised as registrations complete, which is one reason the official series runs across many years rather than trumpeting a single figure. What is stable, and what matters to you, is that bowel cancer is common enough to be worth taking seriously and common enough to justify a national screening programme aimed squarely at catching it early.

Source: Public Health Scotland, Annual Cancer Incidence in Scotland, 2000 to 2024.

Incidence and survival are two different questions

The single most useful distinction on this whole subject is between incidence and survival, because conflating them is how people frighten or falsely reassure themselves.

Incidence counts how many people are newly diagnosed. It answers "how likely am I, or someone like me, to get this." Survival looks only at people who already have the diagnosis and measures how many are still alive after a set period, typically one, five or ten years. It answers "if I were diagnosed, what is the outlook." Those are different worlds. A cancer can be common and survivable, common and dangerous, rare and survivable, or rare and dangerous, in any combination, and you cannot read one measure off the other.

Bowel cancer is a case where the difference really bites, because its survival depends heavily on the stage at which it is found. Caught early, the outlook is far better than when it is found after it has spread, which is precisely why screening and acting on symptoms matter so much. But that survival gradient tells you nothing about how common the disease is — that is still an incidence question, and one you answer from the incidence tables, not the survival ones.

There is a third measure people sometimes reach for as well: mortality, the number of deaths from a cancer in a year. That is different again from both incidence and survival, and it reflects both how many people are diagnosed and how many of them the disease goes on to kill. When you are trying to gauge how common a cancer is, mortality is the wrong tool for the same reason survival is: it is shaped by what happens after diagnosis, not by how likely a diagnosis is. Keep returning to the one question you actually asked, and match it to the one measure that answers it.

Why English figures answer a different question

Most of the authoritative-looking cancer statistics online describe England, because the largest English publications cover England alone. For a Scottish reader that is a double mismatch: often the wrong measure, and almost always the wrong population.

Scotland is not simply a smaller England. It runs its own cancer registry, its own bowel screening programme with its own invitation ages, and it has a different population profile — different age structure, different patterns of smoking, diet and deprivation, all of which feed into how common a cancer is. Applying an English incidence rate to Scotland, or an English survival figure to a Scottish question about how common something is, stacks two errors on top of each other. You end up answering neither the question you asked nor for the place you live.

This is the same trap that catches people comparing themselves against a headline "average age of death" or a period life table, where the measure quietly answers a different question from the one in your head. We take that specific confusion apart in why a period life table will not tell you whether you will reach 85, and the lesson carries straight across to cancer statistics: check which measure you are looking at, and which population it describes, before you let it worry you.

How common bowel cancer actually is in Scotland

Kept to what can be said honestly, the position is this. Bowel cancer sits among the handful of cancers that account for the largest share of new diagnoses in Scotland each year. It is more commonly diagnosed with age, which is why the screening programme is aimed at older adults, and it is one of the cancers where a national screening effort exists precisely because early detection changes outcomes so much.

What you will not get from this page is an invented precise rate, because a wrong number that sounds exact is worse than an honest qualitative one. If you want the current counts for a specific year, sex or health board, the Public Health Scotland incidence publication is the authoritative source, and it is updated as registrations complete. The value of going to it directly is that you get Scottish numbers, for the Scottish population, on the incidence measure — the combination that actually answers "how common is this here."

Source: Public Health Scotland, Annual Cancer Incidence in Scotland, 2000 to 2024.

The Scottish Bowel Screening Programme

The practical reason incidence matters is that Scotland acts on it through screening, and screening is the lever that shifts bowel cancer from a late, dangerous diagnosis to an early, treatable one.

The Scottish Bowel Screening Programme invites everyone aged 50 to 74 every two years, sending a home test kit through the post that looks for hidden blood in a stool sample. It is quick, it is done at home, and returning it is one of the highest-value few minutes of admin available to anyone in that age band. If you are within those ages and a kit has been sitting on the side, completing it is a more useful response to a family worry than any statistic on this page. The programme is described in full on NHS inform, Scotland's national health information service.

Screening is for people without symptoms. If you have symptoms — a persistent change in bowel habit, blood, unexplained weight loss or tiredness — that is not a screening matter, it is a see-your-GP matter, whatever your age and whether or not you are due a kit.

It is also worth knowing that the invitation ages are not identical across the United Kingdom. The Scottish programme's 50-to-74 range is a Scottish arrangement; the English programme has been extending its own starting age down over recent years, and the schemes are administered separately. This is one more reason a Scottish reader is better served by the Scottish programme's own guidance than by an English page describing English ages — the same mismatch, in miniature, as using English statistics to answer a Scottish question.

When a family history changes your screening

Routine screening assumes an average risk. If bowel cancer has affected close relatives, your risk may be above average, and the response is not the postal kit but a conversation with your GP, because a family history can move you onto a different pathway.

Depending on how many relatives were affected, how closely they are related to you, and how young they were at diagnosis, you may be offered colonoscopy surveillance — a direct look at the bowel, starting earlier and repeating more often than the general programme — rather than the home test. Some families carry a specific inherited condition, such as Lynch syndrome, that raises bowel cancer risk substantially and has its own surveillance regime. Your GP is the gateway to all of this, and the thing that lets them judge it is a clear account of who in the family was affected and when.

The best way to give them that is to write it down properly. We explain how to build the picture in our guide to setting out three generations of cancer as a family tree. It is also worth knowing that "a family history of cancer" is defined one way by the NHS for deciding on screening and another way by insurers on an application form, and the two do not match — we set the two definitions of a family history of cancer side by side so you can see which threshold, if any, your situation crosses.

Putting the risk in proportion, and cover

Learning that a cancer is common where you live, and that it runs in your family, is unsettling. Two things keep it in proportion. Most bowel cancer is not inherited even when it appears in a family, so a single affected relative is common and usually is not evidence of a faulty gene. And the measure that decides your outlook — the stage at which anything is caught — is one you can influence, by taking up screening and acting promptly on symptoms, far more than a birthday or a family story can.

If a family history of cancer has also made you think about protecting the people who depend on you, it is worth knowing that a family history is not a bar to life insurance. Applications ask about it in a structured way, and different insurers weigh the same answers differently, which is why an FCA-authorised broker can compare life insurance quotes across the market rather than leaving you with one company's view. Answering the family-history questions accurately matters more than trying to present them in a flattering light.

For the wider picture of how family history, screening and honest disclosure fit together, our guide to family history, inherited risk and the odds pulls the threads into one place.

Frequently asked questions

How common is bowel cancer in Scotland?

Public Health Scotland publishes annual cancer incidence figures for Scotland, and bowel cancer is consistently among the most commonly diagnosed cancers there. Incidence answers how many people are diagnosed, which is a different measure from survival, which describes what happens to people after diagnosis. For current counts by year, sex or health board, the Public Health Scotland incidence publication is the authoritative source.

Why not use English figures?

Because Scotland has its own registry, its own screening programme and a different population profile, and English publications generally cover England alone. Using an English survival statistic to answer a Scottish question about how common a cancer is mixes two measures and two populations at once, so you end up answering neither the question you asked nor for the place you live.

When does bowel screening start in Scotland?

The Scottish Bowel Screening Programme invites people aged 50 to 74 every two years, sending a home test kit through the post. If close relatives have had bowel cancer, speak to your GP, because a family history may lead to colonoscopy surveillance starting earlier and repeating more often, instead of the routine kit.